Constipation is a more common complication in patients with gastrointestinal diseases. In foreign research survey, it was shown that about 30% to 60% of diseases will develop constipation after the onset disease, especially hemorrhagic diseases, there an 80% chance developing within two weeks disease. recent studies, positively correlated severity and severe longer higher likelihood constipatio...

In the article by Jiménez-Ruiz et al., entitled “Neuro-logic manifestations of COVID-19”,1 it was concluded that “we must bear in mind infectious and non-infec-tious complications affect nervous system such as encephalitis, seizures, Guillain-Barre syndrome, dis-seminated encephalomyelitis hemorrhagic leuko-encephalitis, which are disorders can occur during or after viral infections.

ET was first recognized in 1934 by the name of hemorrhagic thrombocythemia. ET is characterized by an unusual thrombocytosis and risk of thrombotic and hemorrhagic disorders. The annual incidence of ET is approximately 1-2.5 per 100,000 population [1]. The incidence of ET is higher in those 50-70 years old, and is most often incidentally detected during a high platelet count. A number of patien...

introduction idiopathic thrombocytopenic purpura is a platelet autoimmune hemostatic disorder. in this study, an itp case with abdominal signs and hemorrhagic corpus luteum is presented. case presentation the patient is a 28-year-old nonpregnant woman admitted to ed for constant acute abdominal pain, accompanied by nausea and vomiting. itp was the prominent disease in her medical history which ...

Viral infections are associated with coagulation disorders. All aspects of the coagulation cascade, primary hemostasis, coagulation, and fibrinolysis, can be affected. As a consequence, thrombosis and disseminated intravascular coagulation, hemorrhage, or both, may occur. Investigation of coagulation disorders as a consequence of different viral infections have not been performed uniformly. Com...

I read with interest the review by Prof. Gutierrez and colleagues on hemorrhagic shock [1]. The treatment of hemorrhagic shock is addressed in the review, and mention is made of the main goals: to stop the source of hemorrhage and to restore the circulating volume. Conserving blood products, on the grounds of cost, restricted availability and their pathophysiological effects, is becoming a nece...

Non-hemorrhagic stroke is a clinical sign of dysfunction or damage to brain tissue due lack blood flow the so that becomes disrupted. The symptoms felt by patient are inability move left extremity resulting in barriers physical mobility. Purpose: describe Nursing Care Non-Hemorrhagic Stroke Mrs.R with Main Diagnosis Physical Mobility Barriers Edelweiss Room Kardinah Hospital, Tegal. Data collec...

Background: Stroke is known to be the third most prominent cause of death in the developing countries and the most common debilitating neurologic disease. This study aimed to investigate the association of platelet count (PC) and mean platelet volume (MPV) index with various stroke types. Methods: This cross-sectional study was carried out on patients over the age of 18 years who presented wit...

Platelet dysfunction is commonly acquired due to medications, procedures, medical conditions, and underlying hematologic disease. These issues are presented, the data reviewed, and recommendations given herein. Many medications and dietary supplements have platelet-inhibitory effects in vitro, although the clinical effects on bleeding risks are unclear for many. Platelet-inhibitory drugs are ke...